Riskpilot← Back to searchSign inGet full accessINNJE AS
ASActiveOrg 991773185Sandakerveien 105, 0483 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 20070 employees
Revenue 2025
NOK 0
EBITDA margin
—
+14% vs 2024
Equity ratio
99.6%
Financial strength
Net profit 2025
NOK 4,9M
+1380% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -111K | +14% |
| Net profit | NOK 4,9M | +1380% |
| Total assets | NOK 12,4M | +58% |
| Equity | NOK 12,4M | +58% |
| Employees | 0 | — |
Legal name
INNJE AS
Org number
991773185
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
3. november 2007
Share capital
NOK 105 600
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Jens-morten wembstad
Company purpose
Investere i aksjer, andre verdipapirer, eiendom, konsulentvirksomhet og det som hører med.
Address
Sandakerveien 105, 0483 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −5 | −5 | −15 |
| EBITDA | −28 | −16 | −44 | −128 | −111 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −28 | −16 | −44 | −128 | −111 |
| Net financials | 779 | 1 467 | 2 406 | −255 | 5 061 |
| Profit before tax | 752 | 1 450 | 2 362 | −383 | 4 951 |
| Tax | −0 | −0 | −0 | −0 | 48 |
| Net profit | 752 | 1 450 | 2 362 | −383 | 4 902 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 742 | 7 319 | 9 321 | 7 854 | 12 420 |
| Equity | 6 088 | 6 959 | 9 321 | 7 819 | 12 372 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 654 | 360 | 0 | 35 | 48 |
| Total debt | 1 654 | 360 | 0 | 35 | 48 |
EBITDA margin
-11061600.0%
This company
15.8%
Market median
-70010227% vs market
20212025
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
39.6%
This company
18.4%
Market median
+115% vs market
20212025
Net profit margin
490233500.0%
This company
8.1%
Market median
+6052265332% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CI Deputy Member | Deputy Member | 2007 |
CI Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2007 | |
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
INNJE AS 
BARN TIL BORDS ASBoard members of INNJE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Inni Holm | Deputy Member | 0 companies |
| Camilla Inni Holm Wembstad | Deputy Member | 0 companies |
| Inni Holm Wembstad | Board of Directors | 0 companies |
| Jens-Morten Wembstad | Chairman | 0 companies |
| Jesper Holm Wembstad | Board of Directors | 0 companies |